AI chatbot aims to ease anxiety and depression in cannabis users
NCT ID NCT06920238
First seen Sep 30, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This early-phase trial is testing whether a generative AI chatbot called Therabot-CALM is usable and acceptable for people who have cannabis use disorder along with anxiety or depression. Fifteen participants will use the app for 4 weeks and give feedback through interviews and questionnaires. The main goal is to see if the app is feasible and liked, not yet to prove it improves symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
46 Centerra Parkway, Suite 300, Office #333S
RECRUITINGLebanon, New Hampshire, 03766, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Therabot-CALM (a generative AI chatbot mobile app)
What this could lead to
If it works, this could point toward a new, accessible way to help people with cannabis use disorder manage anxiety and depression.
What could go wrong
This is a very early, small phase 1 trial with only 15 people, focused on feasibility and usability—not on proving the chatbot works. The app may not be effective or acceptable to users.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.